The main outcome of this work is that the subacute administration of zinc increases the expression of CCL2, CCR2, and growth factors (FGF2 and IGF-1) as well as preventing the loss of memory in the rats after transient hypoxia-ischemia. This evidence concerns the gene IGF1 and ischemia.